434 related articles for article (PubMed ID: 25183264)
1. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence.
Polis CB; Phillips SJ; Curtis KM; Westreich DJ; Steyn PS; Raymond E; Hannaford P; Turner AN
Contraception; 2014 Oct; 90(4):360-90. PubMed ID: 25183264
[TBL] [Abstract][Full Text] [Related]
2. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
[TBL] [Abstract][Full Text] [Related]
3. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.
Ralph LJ; Gollub EL; Jones HE
Curr Opin Obstet Gynecol; 2015 Dec; 27(6):487-95. PubMed ID: 26536211
[TBL] [Abstract][Full Text] [Related]
5. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
6. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
Singata-Madliki M; Smit J; Beksinska M; Balakrishna Y; Avenant C; Beesham I; Seocharan I; Batting J; Hapgood JP; Hofmeyr GJ
PLoS One; 2024; 19(3):e0295764. PubMed ID: 38530848
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
Front Immunol; 2021; 12():760504. PubMed ID: 34956191
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
Heffron R; Achilles SL; Dorflinger LJ; Hapgood JP; Kiarie J; Polis CB; Steyn PS
Contraception; 2019 Apr; 99(4):199-204. PubMed ID: 30576636
[TBL] [Abstract][Full Text] [Related]
10. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.
Crook AM; Ford D; Gafos M; Hayes R; Kamali A; Kapiga S; Nunn A; Chisembele M; Ramjee G; Rees H; McCormack S
Hum Reprod; 2014 Aug; 29(8):1810-7. PubMed ID: 24838704
[TBL] [Abstract][Full Text] [Related]
11. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
12. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence.
Polis CB; Curtis KM
Lancet Infect Dis; 2013 Sep; 13(9):797-808. PubMed ID: 23871397
[TBL] [Abstract][Full Text] [Related]
13. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
Cochrane Database Syst Rev; 2006 Jul; (3):CD005214. PubMed ID: 16856087
[TBL] [Abstract][Full Text] [Related]
14. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
15. Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.
Hapgood JP
AIDS Res Hum Retroviruses; 2020 May; 36(5):357-366. PubMed ID: 31797677
[TBL] [Abstract][Full Text] [Related]
16. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
[TBL] [Abstract][Full Text] [Related]
17. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.
Polis CB; Curtis KM; Hannaford PC; Phillips SJ; Chipato T; Kiarie JN; Westreich DJ; Steyn PS
AIDS; 2016 Nov; 30(17):2665-2683. PubMed ID: 27500670
[TBL] [Abstract][Full Text] [Related]
18. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.
Kleinschmidt I; Rees H; Delany S; Smith D; Dinat N; Nkala B; McIntyre JA
Contraception; 2007 Jun; 75(6):461-7. PubMed ID: 17519153
[TBL] [Abstract][Full Text] [Related]
19. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
Cochrane Database Syst Rev; 2013; 3():CD004568. PubMed ID: 23641480
[TBL] [Abstract][Full Text] [Related]
20. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
Smith JA; Beacroft L; Abdullah F; Buthelezi B; Makua M; Morroni C; Ramjee G; Velasquez C; Hallett TB
J Int AIDS Soc; 2020 Oct; 23(10):e25620. PubMed ID: 33030312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
